Contributions
Stay tuned—this is where the team’s scientific contributions will be shared.
Accolades
Check back soon to see how this team is being recognized.
In the News
On the trail of Parkinson’s: Millions in funding for UMG research team
05/22/2026 — An international collaborative project involving the University Medical Center Göttingen (UMG) has received a grant of approximately 7.7 million euros from the “Aligning Science Across Parkinson’s” research initiative for the next three years.
Decoding the Blueprint: Advancing Personalized Parkinson’s Treatments
05/21/2026 — In our community, we often hear: “If you’ve met one person with Parkinson’s, you’ve met one person with Parkinson’s.” This isn’t just an adage — it’s a biological reality. This radical variability is exactly what makes the disease so difficult to outsmart. We’ve learned that a puzzle this fragmented cannot be solved with a single, broad stroke. Our goal isn’t to find one answer for everyone, but the right answer for the right person at the right time.
UK DRI scientists receive multi-million-dollar awards to tackle Parkinson’s
05/05/2026 — Four scientists from the UK DRI are amongst the recipients of new global team-based research awards announced last week by the Aligning Science Across Parkinson’s Initiative (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), as part of ASAP’s Collaborative Research Network (CRN).
MRC PPU researchers receive major funding to explore new frontiers in Parkinson’s disease
05/05/2026 — Researchers at the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) at the University of Dundee have been awarded a series of major international research grants totalling $18 million from the Aligning Science Across Parkinson’s (ASAP) initiative, in partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF).
MJFF and ASAP Invest $261M in Global Network for Parkinson’s Research
04/30/2026 — Parkinson’s News Today reports that ASAP and The Michael J. Fox Foundation are investing $261 million to expand the Collaborative Research Network (CRN) to better understand what drives Parkinson’s disease and to accelerate the development of more personalized therapies.
